Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |